Treatment with aspirin or interferon is associated with up to ten-fold higher live birth rates in pregnant women with myeloproliferative neoplasms (MPN), research from Canada shows. The findings, published in JAMA Open, are important as two trends – increasing maternal age in general and younger age at diagnosis of MPN – result in more women ...
MPN treatment in pregnancy delivers higher live birth rates
By Mardi Chapman
12 Nov 2019